Acerus Pharma

Acerus is a Canadian pharmaceutical company focused on the development and commercialization of innovative products that improve the patient experience.

[Acerus Pharma @AcerusPharma]

Acerus Announces Amendment to Promissory Note Due to Former Serenity Shareholders
https://t.co/NaXvO6f2zV

[Acerus Pharma @AcerusPharma]

Acerus Announces Initiation of Strategic Review
https://t.co/Uf0aAdzFqm

[Acerus Pharma @AcerusPharma]

Acerus Announces Resignation of CFO Effective November 20, 2022
https://t.co/2GqAkX1k6v

[Acerus Pharma @AcerusPharma]

Acerus Announces Amendments to Loan Facility and Promissory Note Due to Former Serenity Shareholders
https://t.co/ykxGD6IbQ4

[Acerus Pharma @AcerusPharma]

Acerus to Report Q2-2022 Financial Results and Host Investor Call
https://t.co/VShDlEBoWb

[Acerus Pharma @AcerusPharma]

Acerus Announces Voting Results for the 2022 Annual Meeting
https://t.co/jpuORTRcgt

[Acerus Pharma @AcerusPharma]

Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders
https://t.co/ZAftLhxVeK

[Acerus Pharma @AcerusPharma]

Acerus Reports First Quarter 2022 Financial Results
https://t.co/J3unylEYg7

[Acerus Pharma @AcerusPharma]

Acerus To Report Q1-2022 Financial Results And Host Investor Call
https://t.co/XUjDZA0YXr

[Acerus Pharma @AcerusPharma]

Acerus Announces Completion of Share Consolidation
https://t.co/wvMBlJiIw8

[Acerus Pharma @AcerusPharma]

Acerus Announces Share Consolidation
https://t.co/BYu3uRqNpZ

[Acerus Pharma @AcerusPharma]

Acerus Announces Amendments to Loan Facility
https://t.co/hBGfWTvCER

[Acerus Pharma @AcerusPharma]

Acerus To Report Q4 And Full Year 2021 Financial Results And Host Investor Call
https://t.co/bC77ijF0D1

[Acerus Pharma @AcerusPharma]

Acerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva™
https://t.co/5ReBuq3IlO

[Acerus Pharma @AcerusPharma]

Acerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva™
https://t.co/YFd2iCdWr2

[Acerus Pharma @AcerusPharma]

Acerus Announces Amendment to Loan Facilities
https://t.co/w1eNbZBULN

[Acerus Pharma @AcerusPharma]

Acerus Pharmaceuticals Announces Commercial Agreement With Verity Pharmaceuticals for the Promotion of NATESTO® in Puerto Rico
https://t.co/JaNdPVSg2O

[Acerus Pharma @AcerusPharma]

Acerus Announces Amendments to Loan Facilities
https://t.co/x2QGu05p8b

[Acerus Pharma @AcerusPharma]

Acerus Announces Participation in HC Wainwright Conference
https://t.co/xgpocxPJH2

[Acerus Pharma @AcerusPharma]

Acerus to Report Q2-2021 Financial Results and Host Investor Call
https://t.co/rYmAz6HXIA